Submitted by Anonymous (not verified) on 19 February 2026 - 9:10
Human medicines European public assessment report (EPAR): Hulio, adalimumab, Date of authorisation: 17/09/2018, Revision: 19, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Hulio, adalimumab, Date of authorisation: 17/09/2018, Revision: 19, Status: Authorised